|
Association of polygenic-based breast cancer risk prediction with patient management. |
|
|
Employment - Myriad Genetics |
Stock and Other Ownership Interests - Myriad Genetics |
|
|
Employment - Myriad Genetics |
Stock and Other Ownership Interests - Myriad Genetics |
|
|
Employment - Myriad Genetics; Myriad Genetics (I) |
Stock and Other Ownership Interests - Myriad Genetics; Myriad Genetics (I) |
Consulting or Advisory Role - DermTech |
|
|
|
Stock and Other Ownership Interests - UnitedHealthcare |
Research Funding - Confidential Clients of Institution including coauthors (Inst) |
|
|
Employment - United Health Group |
Stock and Other Ownership Interests - United Health Group |
Research Funding - Clients who are confidential to the institution, including coauthors (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Myriad Genetics |
Stock and Other Ownership Interests - Myriad Genetics |
|
|
Employment - Myriad Genetics |
Stock and Other Ownership Interests - Myriad Genetics |
|
|
Employment - Myriad Genetics |
Stock and Other Ownership Interests - Myriad Genetics |
|
|
Employment - Optum/UnitedHealth Group |
Stock and Other Ownership Interests - United Health Group |
Research Funding - Clients who are confidential to the institution, including co-authors (Inst) |
|
|
Employment - Optum/UnitedHealth Group |
Stock and Other Ownership Interests - United Health Group |
Research Funding - Clients who are confidential to the Institution, including coauthors (Inst) |
|
|
Other Relationship - Adela; Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; Gilead Sciences; InVitae; Merck; Myriad Genetics |